2 Result: Biophytis
Biophytis Gains Momentum; bluebird bio Posts Mixed Results
August 08th, 2023
Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program. This initiative marks the first-ever phase 3 study targ. Read more
Breaking: Novartis Q2 Earnings Beat; Sarconeos Deal Boosts Biophytis
July 18th, 2023
Shares of Novartis AG (NYSE: NVS) experienced a surge in premarket trading as the company surpassed expectations in its second-quarter 2023 financial report. The pharmaceutical giant reported core earnings per share (EPS) of $1.83 and sales . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login